Citigroup »

Avita Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $49k 3.6k 13.75
2023-09-30 $220 15 14.67
2023-03-31 $561k 40k 13.97
2022-12-31 $139k 21k 6.60
2021-12-31 $396k 33k 11.98
2021-03-31 $705k 36k 19.81
2020-12-31 $1.0k 69 14.49
2020-09-30 $1.0k 50 20.00
2020-06-30 $2.0k 50 40.00